Filing Flows › HeartSciences (HSCS) › Stock forecast & fair value
HeartSciences (HSCS) stock forecast and price target
HeartSciences (HSCS) trades at $2.83. One analyst's price target is $12.00 (+324%).
HeartSciences' latest quarter
HeartSciences, Q1 FY27: revenue $2K (+10% year over year), net loss $3.2M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for HSCS stock?
One analyst's 12-month target is $12.00, +324% from $2.83. The average rating is none.
Does HeartSciences usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is HSCS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.